Aaron Wealth Advisors
OVID icon

Aaron Wealth Advisors’s Ovid Therapeutics OVID Stock Holding History

Aaron Wealth Advisors’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$24.9K Sell
10,017
-1,217
-11% -$3.18K ﹤0.01% 687
2026
Q2 		$30.2K Hold
11,234
– – ﹤0.01% 686
2026
Q1 		$24.9K Hold
11,234
– – ﹤0.01% 689
2025
Q4 		$18.3K Hold
11,234
– – ﹤0.01% 675
2025
Q3 		$14.6K Sell
11,234
-27,025
-71% -$23.4K ﹤0.01% 629
2025
Q2 		$12.6K Buy
+38,259
New +$11.5K ﹤0.01% 486

Other funds holding OVID

Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Total Clarity Wealth Management
Total Clarity Wealth Management St. Charles, Illinois $518M AUM 17.26% 1-Year Est. Return
Benin Management Corp
Benin Management Corp Wilton, Connecticut $517M AUM 21.33% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
TFC Financial Management
TFC Financial Management Boston, Massachusetts $893M AUM 15.25% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Aaron Wealth Advisors's OVID Position: Q3 2026 in Review

Aaron Wealth Advisors reduced its Ovid Therapeutics (OVID) stake by 11% in Q3 2026, selling an estimated $3.18K and leaving 10,017 shares worth $24.9K. The position accounts for ﹤0.01% of the portfolio, ranked #687.

Aaron Wealth Advisors first reported a position in OVID in Q2 2025 and has held it in 6 quarters since. The position peaked at $30.2K in Q2 2026. 13 funds tracked by Wall St. Rank hold OVID as of Q3 2026.

  • Aaron Wealth Advisors held 10,017 shares of Ovid Therapeutics worth $24.9K as of Q3 2026.
  • Aaron Wealth Advisors sold 1,217 Ovid Therapeutics shares in Q3 2026, an estimated $3.18K.
  • Ovid Therapeutics made up ﹤0.01% of Aaron Wealth Advisors's portfolio in Q3 2026, its #687 holding.
  • Aaron Wealth Advisors first reported a position in Ovid Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • Aaron Wealth Advisors's Ovid Therapeutics position peaked at $30.2K in Q2 2026.
  • 13 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.

Based on Aaron Wealth Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.